Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytes

In chronic inflammatory diseases, such as rheumatoid arthritis, inflammation acts as an independent cardiovascular risk factor and the use of anti-inflammatory drugs, such as anti-tumor necrosis factor alpha (anti-TNFα), may decrease this risk. The phagocytosis of oxidized low density lipoproteins (...

Descripción completa

Detalles Bibliográficos
Autores principales: Boyer, Jean Frédéric, Balard, Patricia, Authier, Hélène, Faucon, Bruno, Bernad, José, Mazières, Bernard, Davignon, Jean-Luc, Cantagrel, Alain, Pipy, Bernard, Constantin, Arnaud
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1906797/
https://www.ncbi.nlm.nih.gov/pubmed/17335569
http://dx.doi.org/10.1186/ar2133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1906797/
https://www.ncbi.nlm.nih.gov/pubmed/17335569
http://dx.doi.org/10.1186/ar2133

Ejemplares similares